¼¼°èÀÇ Ç÷¾× ¹× ü¾× ¿ö¸Ó ½ÃÀå
Blood and Fluid Warmers
»óǰÄÚµå : 1797191
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 376 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Ç÷¾×¡¤Ã¼¾× ¿ö¸Ó ½ÃÀåÀº 2030³â±îÁö 18¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Ç÷¾×¡¤Ã¼¾× ¿ö¸Ó ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 7.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀΠȯÀÚ¿ë º¸¿Â ¾×¼¼¼­¸®´Â CAGR 6.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 11¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¤¸Æ³» °¡¿Â ½Ã½ºÅÛ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 8.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 3,180¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç÷¾×¡¤Ã¼¾× ¿ö¸Ó ½ÃÀåÀº 2024³â¿¡ 3¾ï 3,180¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2024-2030³â¿¡ CAGR 10.8%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 3¾ï 7,880¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.5%¿Í 6.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç÷¾×¡¤Ã¼¾× ¿ö¸Ó ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Ç÷¾× ¹× ü¾× ¿ö¸Ó°¡ Çö´ë ÀÇ·á ¹× ÀÀ±Þ ½Ã¼ú¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Ç÷¾× ¹× ü¾× ¿ö¸Ó´Â ȯÀÚÀÇ »ýÁ¸°ú ȸº¹À» À§ÇØ ¿Âµµ¿¡ ¹Î°¨ÇÑ ¼ö¾× ÁÖÀÔÀÌ ÇʼöÀûÀÎ ÀÇ·á ÇöÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÀåÄ¡´Â Á¤¸ÆÁÖ»ç, Ç÷¾×Á¦Á¦, ±âŸ ¼ö¾×À» Åõ¿©Çϱâ Àü¿¡ ü¿Â¿¡ °¡±õ°Ô °¡¿ÂÇÏ¿© Àúü¿ÂÁõÀ» ¿¹¹æÇϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÀ±ÞÀÇ·á, ¿Ü»ó, ¼ö¼ú, ±¸±Þ ÇöÀå¿¡¼­ Â÷°¡¿î ¼ö¾×À̳ª Ç÷¾×À» ºü¸£°Ô ÁÖÀÔÇϸé À§ÇèÇÑ Ã¼¿Â ÀúÇÏ, ÀÀ°íÀå¾Ö, ºÎÁ¤¸Æ, ¸é¿ª¾ïÁ¦ µîÀÇ ÇÕº´Áõ À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. Ç÷¾× ¹× ü¾× °¡¿Â±â´Â ¼ö¼ú½Ç, ÁßȯÀÚ½Ç, ±¸±ÞÂ÷, ±º ¾ßÀüº´¿ø, ½Å»ý¾Æ½Ç µî ü¿Â º¯È­¿¡ ƯÈ÷ Ãë¾àÇÑ È¯ÀÚµéÀÌ ÀÖ´Â °÷¿¡¼­ ƯÈ÷ ÇʼöÀûÀÎ Á¦Ç°ÀÔ´Ï´Ù. ±× »ç¿ëÀº Æí¾ÈÇÔÀÇ ¹®Á¦»Ó¸¸ ¾Æ´Ï¶ó ´ë·® ¼öÇ÷ ¹× ¼öºÐ ¼Ò»ý¼úÀ» °ü¸®ÇÏ´Â µ¥ ÀÓ»óÀûÀ¸·Î ÇÊ¿äÇÑ °ÍÀÔ´Ï´Ù. ¿Ü»ó, ±³Åë»ç°í, ¼ö¼ú, Àå±â ¼ö¾× ¿ä¹ýÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯ µî Áõ°¡·Î ÀÎÇØ º´¿ø°ú ±¸±Þ´ë´Â ¿Â¿­ ½Ã½ºÅÛ »ç¿ëÀ» Ç¥ÁØÈ­ÇØ¾ß ÇÒ Çʿ伺ÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ ¾ÈÀü¿¡ °üÇÑ ÇÁ·ÎÅäÄݰú Àü ¼¼°è ÀÇ·á °¡À̵å¶óÀο¡¼­´Â ¿Âµµ¿¡ ¹Î°¨ÇÑ ÀÓ»ó ÇöÀå¿¡¼­ÀÇ º£½ºÆ® ÇÁ·¢Æ¼½º·Î ¿Â¿­ ¼ö¾× ÁÖÀÔÀ» ±ÇÀåÇÏ´Â »ç·Ê°¡ ´Ã°í ÀÖ½À´Ï´Ù. ȯÀÚ Á᫐ Áø·á°¡ ´õ¿í Á¤±³ÇØÁü¿¡ µû¶ó ÷´Ü ¼ö¾× °¡¿Â ½Ã½ºÅÛÀÇ Á¸Àç´Â ´Ù¾çÇÑ ÀÓ»ó ȯ°æ¿¡¼­ °íǰÁúÀÇ ½Å¼ÓÇÑ ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ´ë¸í»ç°¡ µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ¼ö¾× ¿ö¸ÓÀÇ ¼º´É°ú Á¢±Ù¼ºÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀ¸·Î Ç÷¾× ¹× ü¾× ¿ö¸ÓÀÇ ¼º´É, È޴뼺, ½Å·Ú¼ºÀÌ Å©°Ô Çâ»óµÇ¾î ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ ´õ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃֽŠÀåÄ¡´Â °Ç¿­, ÀüµµÆÇ, Àû¿Ü¼± °¡¿­À» ÀÌ¿ëÇÑ Á¤È®ÇÑ ¿Âµµ Á¦¾î ½Ã½ºÅÛÀ¸·Î ¼³°èµÇ¾î ¼¼Æ÷ ±¸Á¶¸¦ ¼Õ»ó½ÃŰ°Å³ª ¾à¹°À̳ª Ç÷¾× ¼ººÐÀÇ È¿´ÉÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í ½Å¼ÓÇÏ°í ¾ÈÀüÇÏ°Ô ¾×ü¸¦ µ¥¿öÁÝ´Ï´Ù. ÷´Ü ¼¾¼­¿Í ÀÚµ¿È­µÈ Çǵå¹é ¸ÞÄ¿´ÏÁòÀ» ÅëÇØ ÁÖÀÔ¾×À» ÀûÀýÇÑ ¿Âµµ·Î °¡¿­Çϰí, ÁÖÀÔÇÏ´Â µ¿¾È ¾ÈÀüÇÑ ¸¶Áø ¹üÀ§ ³»¿¡¼­ À¯ÁöµË´Ï´Ù. ±¸±Þ´ë¿ø, ±ºÀǰü, ÀÌ¼ÛÆÀÀÌ ¿­¾ÇÇÑ È¯°æ¿¡¼­µµ »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â ¿Â¿­ ¼ö¾×À» Á¦°øÇÒ ¼ö ÀÖµµ·Ï ¹èÅ͸®·Î ±¸µ¿µÇ´Â ¼ÒÇü ÈÞ´ë¿ëÀÌ ÇöÀå¿ëÀ¸·Î °³¹ßµÇ¾ú½À´Ï´Ù. ÀÏȸ¿ë ¿Â¿­ ¼¼Æ®, ÀÏȸ¿ë īƮ¸®Áö, ÀÏüÇü Æ©ºê ½Ã½ºÅÛ µîÀÇ ±â¼ú Çõ½ÅÀº ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̰í ÀÇ·áÁøÀÇ ÀÛ¾÷ È帧À» ´Ü¼øÈ­ÇÏ¿© ÀÇ·áÁøÀÇ ¾÷¹« È帧À» °£¼ÒÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ ¸¹Àº ¿Â¿­±â´Â ÇöÀç Á÷°üÀûÀÎ »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º, ½Ç½Ã°£ µðÁöÅÐ ¸ð´ÏÅ͸µ, ÀüÀڰǰ­±â·Ï ¹× ¼ö¾× °ü¸® ½Ã½ºÅÛ°ú ÅëÇյǴ ¿¬°á ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â´É °­È­´Â ¼ö¾× °¡¿ÂÀÇ ¾ÈÀü¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ÀçÅÃÄ¡·á, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ¿Ü·¡ ¼ö¾× Ŭ¸®´Ð µî »õ·Î¿î ºÐ¾ß¿¡¼­µµ »ç¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. °¢ Á¦Á¶¾÷üµéÀÌ ³»±¸¼º, ¿¡³ÊÁö È¿À²ÀÌ ¶Ù¾î³­ µðÀÚÀÎ, ´Ù¾çÇÑ ¾×ü À¯Çü°ú ¾×·®¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ´Ù¿ëµµ·Î Çõ½ÅÀ» °ÅµìÇÏ´Â °¡¿îµ¥, Ç÷¾× ¹× ü¾× ¿ö¸ÓÀÇ Àü¹ÝÀûÀÎ Á¢±Ù¼º°ú äÅ÷üÀº Àü ¼¼°è ÇコÄɾî ÇöÀå¿¡¼­ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Ç÷¾× ¹× ü¾× ¿ö¸Ó ¼ö¿ä¸¦ Çü¼ºÇÏ´Â Áö¿ª ¹× ºÐ¾ß µ¿ÇâÀº?

Ç÷¾× ¹× ü¾× ¿ö¸Ó¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¿ª¸¶´Ù ´Ù¸£¸ç, Áö¿ª ÀÇ·á ÀÎÇÁ¶ó, ÀÀ±ÞÀÇ·á Áغñ »óÅÂ, ¿Ü°ú¼ö¼ú ¼öÁØ¿¡ µû¶ó Å©°Ô ¿µÇâÀ» ¹Þ½À´Ï´Ù. ºÏ¹Ì¿Í ¼­À¯·´¿¡¼­´Â ÷´Ü ¿Ü»ó Ä¡·á ½Ã½ºÅÛ°ú ¿Ü°ú¼ö¼úÀÌ °íµµ·Î Ç¥ÁØÈ­µÇ¾î ÀÖÀ¸¸ç, ¼ö¼ú½Ç, ÁßȯÀÚ½Ç, ¿Ü·¡ ¼­ºñ½º¿¡ ü¾× º¸Á¸±â°¡ ±¤¹üÀ§ÇÏ°Ô ÅëÇյǾî ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀÇ ±ÔÁ¦±â°üÀº ¼ö¼ú ¹× ¿Ü»ó Ä¡·á Áß Á¤»ó ü¿Â À¯ÁöÀÇ Á߿伺À» °­Á¶Çϰí ü¾× ¿Â¿­ ÀåÄ¡¸¦ Ä¡·áÀÇ ÀÏ»óÀûÀÎ ¿ä¼Ò·Î »ï°í ÀÖ½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ÀÇ ÀϺΠ±¹°¡¿¡¼­´Â ±Þ¼ÓÇÑ ÀÇ·á Çö´ëÈ­, ¼ö¼ú °Ç¼ö Áõ°¡, ¿Â¿­ À¯Ã¼ÀÇ ÀÓ»óÀû ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡·Î ÀÎÇØ äÅ÷üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àεµ, Áß±¹, ºê¶óÁú µî ½ÅÈï ±¹°¡Àº ¿Ü»ó Ä¡·á ÀÎÇÁ¶ó ¹× ÀÀ±ÞÀÇ·á ¼­ºñ½º¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÈÞ´ë °¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¿Â¿­ ½Ã½ºÅÛ Á¶´ÞÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±º ºÐ¾ßµµ ƯÈ÷ ÇöÀå ÀÇ·á Ȱµ¿ÀÌ È°¹ßÇÑ ±¹°¡¿¡¼­´Â º´¿ø ÀÌ¼Û Àü ºÎ»óÀÚ¸¦ ¾ÈÁ¤½Ã۱â À§ÇØ ¼ÒÇüÀÇ °ß°íÇÑ ¿Â¿­±â°¡ »ç¿ëµÇ¾î Æ´»õ ½ÃÀåÀÇ ¼ºÀåÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ ¼±ÅÃÀû ¼ö¼ú, Àå±âÀ̽Ä, ¿Ü·¡ ¼ö¾×Ä¡·á°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹Î°£ Áø·á¼Ò ¹× µ¥ÀÌÄÉ¾î ½Ã¼³¿¡¼­ÀÇ »ç¿ëµµ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ºñÁ¤ºÎ±â±¸ ¹× ±¹Á¦ ±¸È£ ±â°üÀº ƯÈ÷ Àç³­ Áö¿ªÀ̳ª ¿Üµý Áö¿ª¿¡ ¹èÄ¡Çϱâ À§ÇÑ ºñ»ó Áغñ ŰƮ¿¡ Ç÷¾× ¹× ü¾× ¿ö¸Ó¸¦ Æ÷ÇÔ½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾çÇÑ ºÐ¾ß¿Í Áö¿ª¿¡¼­ÀÇ µ¿ÇâÀº ÀÏ»óÀûÀÎ Ä¡·á¿Í ÁßȯÀÚ Ä¡·á ¸ðµÎ¿¡¼­ ü¾× °¡¿Â ¼Ö·ç¼ÇÀÇ ¹üÀ§°¡ ³Ð¾îÁö°í Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ´Ù´Â °ÍÀ» ÀÔÁõÇÕ´Ï´Ù.

Ç÷¾× ¹× ü¾× ¿ö¸Ó ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?

Ç÷¾× ¹× ü¾× °¡¿Â±â ½ÃÀåÀÇ ¼ºÀåÀº ÀÓ»óÀû ¿ä±¸, ±â¼ú ¹ßÀü, ±ÔÁ¦ Àå·Á, ¼¼°è ÇコÄɾî ÀÎÇÁ¶ó È®´ë µîÀÇ º¹ÇÕÀûÀÎ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ ±Þ¼Ó ¼ö¾× ÁÖÀÔÀÌ ÀϹÝÀûÀÎ ¿Ü»ó, ¼ö¼ú, ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ ¼ö¾×°ú °ü·ÃµÈ Àúü¿ÂÁõÀÇ À§Ç輺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁø °ÍÀÌ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. º´¿øÀÌ È¯ÀÚ °á°ú °³¼±°ú ¼ö¼ú ¾ÈÀü ÇÁ·ÎÅäÄÝ Áؼö¸¦ ¿ì¼±½ÃÇÔ¿¡ µû¶ó ¿Â¿­ ÀåÄ¡ÀÇ »ç¿ëÀº Àü¹® ÅøÀÌ ¾Æ´Ñ Ç¥ÁØ Ä¡·á°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Àåºñ´Â »ç¿ëÇϱ⠽±°í, ÈÞ´ë°¡ °£ÆíÇϸç, ¿¡³ÊÁö È¿À²ÀÌ ¶Ù¾î³ª ÇöÀå ÀÛ¾÷À̳ª Áö¹æ Áø·á¼Ò, ±¸±ÞÂ÷ µî¿¡¼­ÀÇ À¯¿ë¼ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾Ï, ½ÅÀåÁúȯ, ÀÚ°¡¸é¿ªÁúȯ µî Àå±â°£ ¼ö¾× ÁÖÀÔÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯ Áõ°¡·Î ÀÎÇØ ¿Ü·¡¿¡¼­ ÀϰüµÇ°í ¾ÈÀüÇÑ ¿Â¿­½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. FDA¿Í À¯·´ÀǾàǰû(European Medicines Agency)°ú °°Àº ±ÔÁ¦ °¡À̵å¶óÀÎÀº ƯÁ¤ ÀÓ»ó ÀýÂ÷¿¡¼­ ¼ö¾× ¿Â¿­±â »ç¿ëÀ» ±ÇÀåÇϰí ÀÖÀ¸¸ç, º´¿ø°ú ÀÇ·á½Ã¼³¿¡¼­ ¼ö¾× ¿Â¿­±â »ç¿ëÀÌ ´õ¿í È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú Áõ°¡¿Í ȸº¹ ÇÁ·ÎÅäÄÝÀÇ °­È­µµ ÇÑ ¿äÀÎÀ̸ç, ¿Â¿­ ¼ö¾×Àº ȯÀÚÀÇ Ã¼¿ÂÀ» À¯ÁöÇÏ°í ¼ö¼ú ÈÄ È¸º¹À» ºü¸£°Ô ÇÏ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Æ¯È÷ °³¹ßµµ»ó±¹¿¡¼­ °øÁߺ¸°Ç¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϸ鼭 ¼ö¾× ¿Â¿­±â¸¦ Æ÷ÇÔÇÑ Ã·´Ü ÀÇ·á±â±â¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ±º, ÀεµÁÖÀÇ, Àç³­ ´ëÀÀ Ȱµ¿ÀÇ È®´ë, º´¿ø Àü ±¸È£¿¡¼­ ü¾× °¡¿ÂÀÌ ÈĹæ Áö¿øÀÇ ¿ì¼±¼øÀ§°¡ µÇ¸é¼­ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ» Á¾ÇÕÇϸé ÀÇ·á ½Ã½ºÅÛÀÌ ¸ðµç Ä¡·á ȯ°æ¿¡¼­ ´õ ³ôÀº ¼öÁØÀÇ Ä¡·á¸¦ Ãß±¸ÇÔ¿¡ µû¶ó Ç÷¾× ¹× ü¾× ¿ö¸Ó ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

Á¦Ç°(ȯÀÚ¿ë °¡¿Â ¾×¼¼¼­¸®, Á¤¸Æ³» °¡¿Â ½Ã½ºÅÛ, Ç¥¸é °¡¿Â ½Ã½ºÅÛ), ¿ëµµ(ȨÄÉ¾î ¿ëµµ, ±Þ¼º±â ÄÉ¾î ¿ëµµ, ½Å»ý¾Æ ÄÉ¾î ¿ëµµ, ¼ö¼úÀü ÄÉ¾î ¿ëµµ, ±âŸ ¿ëµµ), ÃÖÁ¾»ç¿ëÀÚ(Áø·á¼Ò ÃÖÁ¾»ç¿ëÀÚ, º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Àü¹® ¼¾ÅÍ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¿¡ Äõ¸® ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Blood and Fluid Warmers Market to Reach US$1.8 Billion by 2030

The global market for Blood and Fluid Warmers estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Patient Warming Accessories, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Intravenous Warming System segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$331.8 Million While China is Forecast to Grow at 10.8% CAGR

The Blood and Fluid Warmers market in the U.S. is estimated at US$331.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$378.8 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Blood and Fluid Warmers Market - Key Trends & Drivers Summarized

Why Are Blood and Fluid Warmers Vital in Modern Medical and Emergency Care?

Blood and fluid warmers play a critical role in healthcare settings where temperature-sensitive fluid administration is essential for patient survival and recovery. These devices are designed to heat intravenous fluids, blood products, and other infusions to near-body temperature before administration, thereby preventing hypothermia and improving patient outcomes. In emergency care, trauma situations, surgeries, and critical care units, the rapid infusion of cold fluids or blood can lead to a dangerous drop in core body temperature, increasing the risk of complications such as coagulopathy, cardiac arrhythmias, and immunosuppression. Blood and fluid warmers are particularly indispensable in operating rooms, intensive care units, ambulances, military field hospitals, and even neonatal units where patients are especially vulnerable to temperature shifts. Their use is not only a matter of comfort but a clinical necessity in managing massive transfusions and fluid resuscitation. The growing prevalence of trauma cases, road accidents, surgeries, and chronic diseases requiring long-term infusion therapies is pushing hospitals and emergency responders to standardize the use of warming systems. Additionally, patient safety protocols and global medical guidelines increasingly recommend warmed infusions as a best practice in temperature-sensitive clinical scenarios. As patient-centric care becomes more refined, the presence of advanced fluid warming systems is becoming synonymous with high-quality and responsive healthcare delivery across a range of clinical environments.

How Are Technological Advancements Elevating the Performance and Accessibility of Fluid Warmers?

Technological innovation is driving significant improvements in the performance, portability, and reliability of blood and fluid warmers, allowing them to be more widely used across diverse medical settings. Modern devices are engineered with precise temperature control systems that use dry heat, conduction plates, or infrared heating to warm fluids quickly and safely without damaging cellular structures or compromising the efficacy of medications and blood components. Advanced sensors and automated feedback mechanisms ensure that fluids are heated to the correct temperature and maintained within safe margins throughout infusion. Compact, battery-operated, and portable models are being developed for field use, enabling emergency responders, military medics, and transport teams to deliver life-saving warmed fluids even in austere environments. Innovations in disposable warming sets, single-use cartridges, and integrated tubing systems are also reducing the risk of cross-contamination and simplifying workflows for medical staff. Moreover, many warmers now come with intuitive user interfaces, real-time digital monitoring, and connectivity features that integrate with electronic health records and infusion management systems. These enhancements are not only improving the safety and efficiency of fluid warming but also expanding their use into new areas such as home healthcare, ambulatory surgery centers, and outpatient infusion clinics. As manufacturers continue to innovate with durable, energy-efficient designs and versatile compatibility with a range of fluid types and volumes, the overall accessibility and adoption of blood and fluid warmers are steadily increasing across global healthcare landscapes.

What Regional and Sectoral Trends Are Shaping the Demand for Blood and Fluid Warmers?

The demand for blood and fluid warmers varies by region and is heavily influenced by local healthcare infrastructure, emergency care readiness, and surgical activity levels. In North America and Western Europe, where advanced trauma care systems and surgical procedures are highly standardized, there is widespread integration of fluid warmers in operating rooms, intensive care units, and ambulatory services. Regulatory agencies in these regions emphasize the importance of maintaining normothermia during surgical and trauma procedures, making fluid warming devices a routine component of care. In contrast, countries in Asia-Pacific, Latin America, and parts of the Middle East are experiencing growing adoption rates due to rapid healthcare modernization, increased surgical volumes, and rising awareness about the clinical benefits of warmed fluids. Emerging economies such as India, China, and Brazil are investing in trauma care infrastructure and emergency medical services, which is translating into increased procurement of portable and cost-effective warming systems. The military sector also represents a growing niche, particularly in countries with active field medical operations, where compact and rugged warmers are used to stabilize wounded personnel before hospital transfer. Moreover, the global rise in elective surgeries, organ transplants, and outpatient infusion treatments is expanding the use of these devices in private clinics and day-care facilities. Non-governmental organizations and international relief agencies are incorporating blood and fluid warmers into their emergency preparedness kits, especially for deployment in disaster zones and remote areas. These varied sectoral and regional trends underscore the broadening scope and essential role of fluid warming solutions in both routine and critical care settings.

What Are the Primary Drivers Fueling the Growth of the Blood and Fluid Warmers Market?

The growth in the blood and fluid warmers market is driven by a combination of clinical needs, technological progress, regulatory encouragement, and expanding healthcare infrastructure worldwide. A significant driver is the increased awareness of the dangers of infusion-related hypothermia, especially in trauma, surgery, and critical care environments where rapid infusion is common. As hospitals prioritize improved patient outcomes and compliance with surgical safety protocols, the use of warming devices is becoming a standard of care rather than a specialty tool. Technological innovations are also making these devices more user-friendly, portable, and energy-efficient, which expands their utility in field operations, rural clinics, and emergency transport vehicles. Additionally, the global increase in chronic illnesses requiring long-term infusions, such as cancer, kidney disease, and autoimmune disorders, is expanding the demand for consistent and safe warming systems in outpatient settings. Regulatory guidelines from agencies such as the FDA and European Medicines Agency increasingly recommend the use of fluid warmers in specific clinical procedures, further pushing their adoption in hospitals and healthcare facilities. The rise of minimally invasive surgeries and enhanced recovery protocols is another contributing factor, as warmed fluids help maintain patient body temperature and support faster postoperative recovery. Furthermore, rising investment in public health, especially in developing regions, is enhancing access to advanced medical equipment, including fluid warmers. Growing military, humanitarian, and disaster response activities also contribute to market growth as fluid warming becomes a logistical priority in pre-hospital care. These drivers collectively ensure that the market for blood and fluid warmers will continue to expand as healthcare systems strive for higher standards of care across all treatment environments.

SCOPE OF STUDY:

The report analyzes the Blood and Fluid Warmers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Patient Warming Accessories, Intravenous Warming System, Surface Warming System); Application (Homecare Application, Acute Care Application, Newborn Care Application, Preoperative Care Application, Other Applications); End-User (Clinics End-User, Hospitals End-User, Specialty Centers End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â